Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

A Savvy Investment in the “Next Generation of Restaurant Franchising through Ghost Kitchens”

(CLICK IMAGE TO PLAY VIDEO) Since before the COVID-19 pandemic, practical, alternative solutions to in-restaurant dining have been growing into a huge economic boom. Case in point ghost kitchens – sometimes called a virtual or cloud kitchen – a restaurant w...

Vivus Shares Climb 50% Higher on sNDA Approval for Exocrine Pancreatic Insufficiency Drug

Shares of Vivus traded higher after the FDA approved the company's supplemental New Drug Application for an improved formulation of PANCREAZE® (pancrelipase) for use in the treatment of exocrine pancreatic insufficiency due to cystic fibrosis and other conditions. ...

Science FACT: The Future of Food is Here…Today

Welcome to the future of food science…happening right now. CULT Food Science Corp. ( CSE.CULT , OTCQB:CULTF , Forum ) is an innovative platform advancing the future of food with an exclusive focus on cultivated meat, cultured dairy, and cell-based foods. The first...

A Splendid Investment Opportunity…Naturally

(Click image to play video) We’re just about smackdab in the middle of New Year’s resolution time, and millions of North Americans are committing to a healthier lifestyle or just trying to shed a few pounds. Coquitlam, BC-based...

Memphasys, Moderna, Paion - Investments in solutions with potential

Biotech companies around the world employ scientists and physicians to study the causes of diseases. The research and development of medical products and solutions usually involves a large number of tests and takes a correspondingly long time. The longer and more extensive thi...

Burcon NutraScience, Saturn Oil & Gas, Very Good Food - good Canadian companies with potential

Canada is a country with many creative and enterprising people. Metropolises such as Toronto and Vancouver offer a lot of potential for new business ideas. But also, in cities of the provinces many entrepreneurs start their adventures and want to improve the world. Canadian Pr...

'Undervalued' Biopharma Gets Breakthrough Status for Alzheimer's Agitation Drug

Axsome Therapeutics' latest news and clinical outlook are discussed in an H.C. Wainwright & Co. report. In a June 30 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that the U.S. Food and Drug Administration (FDA) designated Axsome Therapeutics...

Biopharma's Phase 3 Trial Results in Migraine 'Robust,' 'Impressive'

These topline data and next steps for the therapeutic are reviewed in a Ladenburg Thalmann report. In a Dec. 30 research note, analyst Matthew Kaplan reported that Ladenburg Thalmann increased its price target on Buy-rated Axsome Therapeutics Inc. (AXSM:NASDAQ) to $...

Odd Burger, disrupting the fast food industry

Odd Burger (TSXV:ODD) is on a mission to disrupt the conventional fast food industry. The Ontario-based, entirely vegan company produces fast food made from scratch using plant-based, minimally processed and sustainable ingredients and also has nine restaurant locatio...

The Greatest Depression Just Began. This Is No Drill.

Exactly a month ago I warned that the coronavirus outbreak was going to pop the "Everything Bubble ." I did something fairly subtle. I buried my main message under a whole heap of cow manure. It doesn't make a rat's ass if I was right or wrong about calling for a market ...
1 2 3 4 5 6 7 8 9 10 ...